Taiwan FDA registration ad4ce9f6297e3ffadf38fe8b6fbdfd24

Yilimetry blood glucose/cholesterol/uric acid monitoring system

TW: 易立測 血糖/膽固醇/尿酸 監測系統
Taiwan flagTaiwan·Risk Class 2·Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd·Registered May 03, 2017 – May 03, 2027Active
Registration details
Analysis ID
ad4ce9f6297e3ffadf38fe8b6fbdfd24
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
This product is only for in vitro testing, using fresh fingertip microvascular whole blood to quantitatively detect blood sugar, cholesterol and uric acid. This product can be used by self-testing and professionals, but is not intended for testing of newborns.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1775 Uric acid testing system;; A.1345 Glucose Test System;; A.1175 Cholesterol (Total) Testing System
Import Information
Contract manufacturing;; Domestic
Dates and status
Registration Date
May 03, 2017
Expiry Date
May 03, 2027
About this record

Access comprehensive regulatory information for Yilimetry blood glucose/cholesterol/uric acid monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ad4ce9f6297e3ffadf38fe8b6fbdfd24 and manufactured by Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd. The authorized representative in Taiwan is EASY LIFE GREEN TECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices